Harwell Science Park aerial view
Harwell Campus UK

About the Nucleic Acid Therapy Accelerator (NATA) & Nucleic Acid Therapies (NATs)

The Nucleic Acid Therapy Accelerator (NATA) is an independent, not-for-profit Medical Research Council (MRC) unit. Our mission is to advance the development of NATs and associated technologies through high-quality science, collaborations and interdisciplinary research. We work with world-leading academics, clinicians, businesses and charities, bringing together a diverse network of expertise, skills and innovative technologies to bridge translational gaps in NAT development. We have the flexibility to focus on new chemical platform development and any disease area or gene target, and the agility to initiate new projects and collaborations quickly. We can also provide training in oligonucleotide therapeutics and knowledge exchange.

 

Nucleic Acid Therapies (NATs) have emerged as a major new class of medicines, offering enormous potential to treat a range of common and rare and diseases. The timescales for NAT development can be quicker than other classes of drugs. In addition, NATs provide opportunities to tailor treatments to individual patients based on their genome sequence. However, the broader clinical application of NATs can be limited by current methods of manufacture and delivery.
Pretty Landscaping & Gardens at Harwell Science Park
Harwell Campus UK